ALHC president sells 30,000 company shares

Alignment Healthcare President Dawn Christine Maroney sold 30,000 shares of common stock in an open-market transaction.

Accepted by SEC EDGAR 02/17/2026 - 07:53 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare President Dawn Christine Maroney sold 30,000 shares of common stock in an open-market transaction. The sale on 2026-02-17 was executed under a Rule 10b5-1 trading plan adopted on 05/22/2025, at a weighted-average price of $20.633 per share. After this transaction, she directly holds 997,015 shares of Alignment Healthcare common stock.

Insider Trade Summary

Net Seller: 30,000 shares

Net Sell 1 txn

Insider Maroney Dawn Christine

Role President

Sold 30,000 shs ($619K)

Type	Security	Shares	Price	Value
Sale	Common Stock	30,000	$20.633	$619K

Holdings After Transaction: Common Stock — 997,015 shares (Direct)

Footnotes (2)

1. F1. Date of Rule 10b5-1 plan adoption: 05/22/2025
2. F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.05 to $20.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ALHC President Dawn Christine Maroney report?

Dawn Christine Maroney reported an open-market sale of 30,000 shares of Alignment Healthcare common stock. The transaction occurred on 2026-02-17 and was reported on Form 4 as a non-derivative transaction labeled as a sale in the company’s common stock.

At what price did the ALHC insider sell the 30,000 shares of stock?

The 30,000 Alignment Healthcare shares were sold at a weighted-average price of $20.633 per share. Footnote F2 explains that the shares were sold in multiple trades, with individual prices ranging from $20.05 to $20.99 across the executed transactions.

How many ALHC shares does Dawn Christine Maroney own after this Form 4 sale?

After the reported sale, Dawn Christine Maroney directly owns 997,015 shares of Alignment Healthcare common stock. This post-transaction ownership figure is disclosed in the Form 4 as the total number of shares she held following completion of the 30,000-share disposition.

Was the ALHC insider stock sale made under a Rule 10b5-1 plan?

Yes, the sale was made under a Rule 10b5-1 trading plan. Footnote F1 states that the plan governing these transactions was adopted on 05/22/2025, indicating the trades were pre-arranged according to that established automated trading instruction.

What does the weighted-average price disclosure mean for the ALHC insider sale?

The weighted-average price of $20.633 reflects multiple individual trades between $20.05 and $20.99 per share. Footnote F2 notes the insider will provide full details of the number of shares sold at each specific price within that range upon request.

What type of security was involved in this ALHC Form 4 transaction?

The Form 4 transaction involved Alignment Healthcare common stock as a non-derivative security. The filing specifies that 30,000 shares of common stock were sold in an open-market transaction, reducing the insider’s directly held common stock position to 997,015 shares afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		S(1)		30,000	D	$20.633(2)	997,015	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Date of Rule 10b5-1 plan adoption: 05/22/2025

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.05 to $20.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.